Can a Hand-Based therapy ease COPD's toughest symptoms?

NCT ID NCT07746596

First seen Aug 05, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This trial investigates whether Su Jok therapy, a complementary technique that stimulates specific points on the hands, can reduce dyspnea (breathlessness) and fatigue in people with chronic obstructive pulmonary disease (COPD). The study will include 30 hospitalized adults with COPD who will receive Su Jok therapy daily for five days alongside their usual care. Researchers will measure changes in symptom severity using visual analog scales. The goal is to see if this safe, non-invasive approach can offer additional relief and improve quality of life for COPD patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Su Jok therapy, a hand-based complementary technique involving stimulation of specific points on the hands
What this could lead to
If effective, Su Jok therapy could offer a safe, drug-free way to help COPD patients manage breathlessness and fatigue, potentially improving their quality of life.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply broadly. The therapy's benefits are uncertain, and it is not a replacement for standard COPD treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Erzincan Binali Yıldırım University

    Erzincan, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.